Nature Medicine

Nature Medicine is an academic journal publishing research articles, reviews, news and commentaries in the biomedical area, including both basic research and early-phase clinical research. Topics covered include cancer, cardiovascular disease, gene therapy, immunology, vaccines, and neuroscience. The journal seeks to publish research papers that demonstrate novel insight into disease processes, with direct evidence of the physiological relevance of the results. Founded in 1995, Nature Medicine is published by the Nature Publishing Group, a division of Macmillan Publishers Ltd, and is one of the rapidly expanding stable of Nature journals. As with other Nature journals, there is no external Editorial Board, with editorial decisions being made by an in-house team, although peer review by external expert referees forms a part of the review process. Nature Medicine is published monthly. Articles are archived online in text and PDF formats; access is by subscription only. Its 2010 impact factor was 25.430, making it the highest-cited research journal in preclinical medicine. It is also among the highest impact of primary (non-review) scientific journals.

Publisher
Nature Publishing Group
History
1995–present
Impact factor
25.430 (2010)
Some content from Wikipedia, licensed under CC BY-SA

Single cell focus reveals hidden cancer cells

Researchers have found a way to identify rogue cancer cells which survive treatment after the rest of the tumour is destroyed, by using a new technique that enables them to identify and characterise individual cancer cells.

May 16, 2017
popularity46 comments 0

Cannabis reverses aging processes in the brain

Memory performance decreases with increasing age. Cannabis can reverse these ageing processes in the brain. This was shown in mice by scientists at the University of Bonn with their colleagues at The Hebrew University of ...

May 08, 2017
popularity18885 comments 6

Studying bone loss mechanism in space

Researchers at Hong Kong Baptist University are conducting a study on board China's spacecraft Tianzhou-1 in order to understand the effect of the "CKIP-1" gene on bone formation under microgravity in space.

May 17, 2017
popularity0 comments 0